Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Reunion Neuroscience

Request full access

Reunion Neurology specializes in neurological treatment and research

Philadelphia, United StatesFounded 2019Biotech & Life Sciences

About Reunion Neuroscience

Reunion Neuroscience is an early-stage pharmaceutical company focused on the discovery and development of proprietary drug candidates designed to engage serotonergic receptors in the brain. The company aims to push the boundaries of neuroscience to create safer and more accessible therapeutics for millions of people whose mental health needs are not met by current treatments. Reunion Neuroscience operates in the pharmaceutical and biotechnology market, primarily serving patients suffering from depression and other mental health disorders. The business model involves extensive research and development (R&D) to create novel drug candidates, which are then brought to market through clinical trials and regulatory approval processes. Revenue is generated through the commercialization of these therapeutics, either directly or through partnerships and licensing agreements with larger pharmaceutical companies. The company is dedicated to transforming lives by making mental and emotional wellbeing the baseline for everyone.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
31
Open positions
None listed
Dealroom signal
87.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Psychedelic Drugs, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Sep 2025 $30M $515M Undisclosed ↗
SERIES AOther financing May 2024 $103M $412M Mitsui · Palo Santo Venture Fund · Plaisance Capital · MPM BioImpact ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Reunion Neuroscience website traffic

Latest recorded traffic for Reunion Neuroscience is 6.3K monthly website visits, up 125% over the last three months. Reunion Neuroscience's team grew 6.9% over the past year.

Latest monthly visits6.3K 3-month web change+125% 1-year team growth+6.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Reunion Neuroscience in the Philadelphia ecosystem

Live from Dealroom

The Reunion Neuroscience office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Novo Holdings
  • Mitsui
  • Palo Santo Venture Fund
  • Plaisance Capital
  • Arkin Capital
  • FemHealth Ventures

Series B and later1 investor entered at this stage

  • MPM BioImpact
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States78.6%
🇨🇦 Canada17.9%
🇯🇵 Japan3.6%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Reunion Neuroscience on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Reunion Neuroscience’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.